Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.55 USD | -5.49% | -15.53% | -34.32% |
Mar. 27 | Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024 | |
Mar. 27 | GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 28.74M | Capitalization | 106M |
---|---|---|---|---|---|
Net income 2024 * | -40M | Net income 2025 * | -30M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.68 x |
P/E ratio 2024 * |
-2.8
x | P/E ratio 2025 * |
-4.79
x | Employees | 35 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.92% |
Latest transcript on GlycoMimetics, Inc.
1 day | -5.49% | ||
1 week | -15.53% | ||
Current month | -48.33% | ||
1 month | -49.01% | ||
3 months | -54.41% | ||
6 months | +19.23% | ||
Current year | -34.32% |
Managers | Title | Age | Since |
---|---|---|---|
Harout Semerjian
CEO | Chief Executive Officer | 52 | 21-08-05 |
Rachel King
FOU | Founder | 64 | 03-04-03 |
Brian Hahn
DFI | Director of Finance/CFO | 49 | 10-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 16-03-16 |
Patricia Andrews
BRD | Director/Board Member | 66 | 17-06-11 |
Scott Jackson
BRD | Director/Board Member | 60 | 18-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.64 | -4.09% | 1,015,401 |
24-04-25 | 1.71 | -7.82% | 547,997 |
24-04-24 | 1.855 | +1.09% | 664,799 |
24-04-23 | 1.835 | +1.94% | 1,231,604 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.32% | 106M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- GLYC Stock